Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 279

Results For "IMI"

4535 News Found

Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr
News | April 27, 2023

Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr

The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023


Serum & Biocon Biologics agree to restructure equity investment
News | April 25, 2023

Serum & Biocon Biologics agree to restructure equity investment

Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio


Tricog raises US$ 8.5 million in series B2 funding
News | April 25, 2023

Tricog raises US$ 8.5 million in series B2 funding

The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa


Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr
News | April 25, 2023

Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr

The business and product range of Ipca and that of Unichem complements each others business and product range


Aster RV Hospital launch needleless injections in South India
News | April 25, 2023

Aster RV Hospital launch needleless injections in South India

A special technique of jet injection is used to make vaccination almost painless and totally needleless.


Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
News | April 25, 2023

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology


Zydus receives final approval from the USFDA for Metronidazole Topical Cream
Drug Approval | April 25, 2023

Zydus receives final approval from the USFDA for Metronidazole Topical Cream

Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea


Indica Labs and Lunit enters into alliance for digital pathology AI workflows
Digitisation | April 25, 2023

Indica Labs and Lunit enters into alliance for digital pathology AI workflows

Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution


Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Drug Approval | April 24, 2023

Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules

Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels


USFDA suggests corrective measures to Sun Pharmaceutical’s Mohali facility
Drug Approval | April 24, 2023

USFDA suggests corrective measures to Sun Pharmaceutical’s Mohali facility

The USFDA had classified the inspection as "Official Action Indicated" (OAI).